Late toxicity and quality of life with prostate only or whole pelvic radiation therapy in high risk prostate cancer (POP-RT): A randomised trial

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · International Journal of Cancer · 2018 · 7.8K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial

Mack Roach, Jennifer Moughan, C.A. Lawton et al. · The Lancet Oncology · 2018 · 231 citations · Full text

Medicine, Oncology, Urology +17

Is There a Role for Pelvic Irradiation in Localized Prostate Adenocarcinoma? Update of the Long-Term Survival Results of the GETUG-01 Randomized Study

P. Pommier, Sylvie Chabaud, Jean‐Léon Lagrange et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 170 citations

Medicine, Oncology, Urology +17

Late Toxicity After Intensity-Modulated Radiation Therapy for Localized Prostate Cancer: An Exploration of Dose–Volume Histogram Parameters to Limit Genitourinary and Gastrointestinal Toxicity

Aaron Pederson, Janine Fricano, David Correa et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 119 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy

Victoria A. Harris, John Staffurth, Olivia Naismith et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 107 citations

Medicine, Radiation Oncology, Urology +16